These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
2851 |
|
||||||||||||
|
(State or other jurisdiction of
incorporation or organization) |
(Primary Standard Industrial
Classification Code Number) |
(I.R.S. Employer
Identification No.) |
||||||||||||
|
|
|
|
||||||||||||
| (Title of class) | (Trading symbol) | (Exchange on which registered) | ||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | |||||||||||||||||||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||
| Cost of goods sold |
|
|
|
|
||||||||||||||||||||||||||||||||||
| Selling, general and administrative expenses |
|
|
|
|
||||||||||||||||||||||||||||||||||
| Other operating charges |
|
|
|
|
||||||||||||||||||||||||||||||||||
| Research and development expenses |
|
|
|
|
||||||||||||||||||||||||||||||||||
| Amortization of acquired intangibles |
|
|
|
|
||||||||||||||||||||||||||||||||||
| Income from operations |
|
|
|
|
||||||||||||||||||||||||||||||||||
| Interest expense, net |
|
|
|
|
||||||||||||||||||||||||||||||||||
| Other expense (income), net |
|
(
|
|
(
|
||||||||||||||||||||||||||||||||||
| Income before income taxes |
|
|
|
|
||||||||||||||||||||||||||||||||||
| Provision (benefit) for income taxes |
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Net income |
|
|
|
|
||||||||||||||||||||||||||||||||||
| Less: Net income (loss) attributable to noncontrolling interests |
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Net income attributable to controlling interests | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||
| Basic net income per share | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||
| Diluted net income per share | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | |||||||||||||||||||||||||||||||||||
| Net income | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||
| Other comprehensive income (loss), before tax: | ||||||||||||||||||||||||||||||||||||||
| Foreign currency translation adjustments |
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||
| Unrealized gain (loss) on derivatives |
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||
| Unrealized (loss) gain on pension plan obligations |
(
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss), before tax |
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||
| Income tax provision (benefit) related to items of other comprehensive income (loss) |
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss), net of tax |
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||
| Comprehensive income (loss) |
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Less: Comprehensive (loss) income attributable to noncontrolling interests |
(
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Comprehensive income (loss) attributable to controlling interests | $ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||
| September 30, 2020 | December 31, 2019 | |||||||||||||
| Assets | ||||||||||||||
| Current assets: | ||||||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
||||||||||
| Restricted cash |
|
|
||||||||||||
| Accounts and notes receivable, net |
|
|
||||||||||||
| Inventories |
|
|
||||||||||||
| Prepaid expenses and other current assets |
|
|
||||||||||||
| Total current assets |
|
|
||||||||||||
| Property, plant and equipment, net |
|
|
||||||||||||
| Goodwill |
|
|
||||||||||||
| Identifiable intangibles, net |
|
|
||||||||||||
| Other assets |
|
|
||||||||||||
| Total assets | $ |
|
$ |
|
||||||||||
| Liabilities, Shareholders’ Equity | ||||||||||||||
| Current liabilities: | ||||||||||||||
| Accounts payable | $ |
|
$ |
|
||||||||||
| Current portion of borrowings |
|
|
||||||||||||
| Other accrued liabilities |
|
|
||||||||||||
| Total current liabilities |
|
|
||||||||||||
| Long-term borrowings |
|
|
||||||||||||
| Accrued pensions |
|
|
||||||||||||
| Deferred income taxes |
|
|
||||||||||||
| Other liabilities |
|
|
||||||||||||
| Total liabilities |
|
|
||||||||||||
| Commitments and contingencies (Note 5) |
|
|
||||||||||||
| Shareholders’ equity: | ||||||||||||||
|
Common shares, $
|
|
|
||||||||||||
| Capital in excess of par |
|
|
||||||||||||
| Retained earnings |
|
|
||||||||||||
|
Treasury shares, at cost,
|
(
|
(
|
||||||||||||
| Accumulated other comprehensive loss |
(
|
(
|
||||||||||||
| Total Axalta shareholders’ equity |
|
|
||||||||||||
| Noncontrolling interests |
|
|
||||||||||||
| Total shareholders’ equity |
|
|
||||||||||||
| Total liabilities and shareholders’ equity | $ |
|
$ |
|
||||||||||
| Common Stock | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Number of Shares | Par/Stated Value | Capital In Excess Of Par | Retained Earnings | Treasury Shares, at cost | Accumulated Other Comprehensive Loss | Non controlling Interests | Total | ||||||||||||||||||||||||||||||||||||||||||||||
| Balance at December 31, 2019 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||
| Comprehensive income (loss): | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — |
|
— | — |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Net realized and unrealized loss on derivatives, net of tax benefit of $
|
— | — | — | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Long-term employee benefit plans, net of tax benefit of $
|
— | — | — | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Foreign currency translation, net of tax of $
|
— | — | — | — | — |
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
| Total comprehensive income (loss) | — | — | — |
|
— |
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
| Cumulative effect of an accounting change | — | — | — |
(
|
— | — | — |
(
|
|||||||||||||||||||||||||||||||||||||||||||||
| Recognition of stock-based compensation | — | — |
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||||||||
| Shares issued under compensation plans |
|
|
(
|
— | — | — | — |
(
|
|||||||||||||||||||||||||||||||||||||||||||||
| Ownership changes relating to noncontrolling interests | — | — |
|
— | — | — |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
| Dividends declared to noncontrolling interests | — | — | — | — | — | — |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
| Balance at March 31, 2020 |
|
|
|
|
(
|
(
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Comprehensive income (loss): | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net loss | — | — | — |
(
|
— | — |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Net realized and unrealized loss on derivatives, net of tax benefit of $
|
— | — | — | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Long-term employee benefit plans, net of tax of $
|
— | — | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Foreign currency translation, net of tax of $
|
— | — | — | — | — |
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Total comprehensive income (loss) | — | — | — |
(
|
— |
|
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
| Recognition of stock-based compensation | — | — |
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||||||||
| Shares issued under compensation plans |
|
|
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||||||||
| Changes in redeemable noncontrolling interest | — | — |
(
|
— | — | — |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
| Common stock purchases | — | — | — | — |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||||||||||||||||||
| Balance at June 30, 2020 |
|
|
|
|
(
|
(
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Comprehensive income (loss): | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — |
|
— | — | — |
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Net realized and unrealized gain on derivatives, net of tax of $
|
— | — | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Long-term employee benefit plans, net of tax of $
|
— | — | — | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Foreign currency translation, net of tax of $
|
— | — | — | — | — |
|
(
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Total comprehensive income (loss) | — | — | — |
|
— |
|
(
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Recognition of stock-based compensation | — | — |
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||||||||
| Shares issued under compensation plans |
|
|
(
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||||||||
| Balance at September 30, 2020 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||
| Common Stock | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Number of Shares | Par/Stated Value | Capital In Excess Of Par | Retained Earnings | Treasury Shares, at cost | Accumulated Other Comprehensive Loss | Non controlling Interests | Total | ||||||||||||||||||||||||||||||||||||||||||||||
| Balance at December 31, 2018 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||
| Comprehensive income: | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — |
|
— | — |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Net realized and unrealized loss on derivatives, net of tax benefit of $
|
— | — | — | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Long-term employee benefit plans, net of tax of $
|
— | — | — | — | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Foreign currency translation, net of tax of $
|
— | — | — | — | — |
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Total comprehensive income | — | — | — |
|
— |
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Cumulative effect of an accounting change | — | — | — |
(
|
— | — | — |
(
|
|||||||||||||||||||||||||||||||||||||||||||||
| Recognition of stock-based compensation | — | — |
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||||||||
| Shares issued under compensation plans |
|
|
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||||||||
| Ownership changes relating to noncontrolling interests | — | — |
|
— | — | — |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
| Common stock purchases |
(
|
— | — | — |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||||||||||||||||||
| Dividends declared to noncontrolling interests | — | — | — | — | — | — |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
| Balance at March 31, 2019 |
|
|
|
|
(
|
(
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Comprehensive income (loss): | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — |
|
— | — |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Net realized and unrealized loss on derivatives, net of tax benefit of $
|
— | — | — | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Long-term employee benefit plans, net of tax benefit of $
|
— | — | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Foreign currency translation, net of tax of $
|
— | — | — | — | — |
(
|
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
| Total comprehensive income (loss) | — | — | — |
|
— |
(
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Correction to previous cumulative effect upon adoption of ASU 2014-09 | — | — | — |
(
|
— | — | — |
(
|
|||||||||||||||||||||||||||||||||||||||||||||
| Recognition of stock-based compensation | — | — |
(
|
— | — | — | — |
(
|
|||||||||||||||||||||||||||||||||||||||||||||
| Shares issued under compensation plans |
|
|
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||||||||
| Ownership changes relating to noncontrolling interests | — | — |
(
|
— | — | — |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
| Common stock purchases |
(
|
— | — | — |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||||||||||||||||||
| Balance at June 30, 2019 |
|
|
|
|
(
|
(
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Comprehensive income (loss): | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — |
|
— | — |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Net realized and unrealized loss on derivatives, net of tax benefit of $
|
— | — | — | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Long-term employee benefit plans, net of tax of $
|
— | — | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Foreign currency translation, net of tax of $
|
— | — | — | — | — |
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
| Total comprehensive income (loss) | — | — | — |
|
— |
(
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Recognition of stock-based compensation | — | — |
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||||||||
| Shares issued under compensation plans |
|
|
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||||||||
| Changes in ownership of noncontrolling interests | — | — | — | — | — | — |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
| Dividends declared to noncontrolling interests | — | — | — | — | — | — |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
| Balance at September 30, 2019 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||
| Nine Months Ended September 30, | ||||||||||||||||||||
| 2020 | 2019 | |||||||||||||||||||
| Operating activities: | ||||||||||||||||||||
| Net income | $ |
|
$ |
|
||||||||||||||||
| Adjustment to reconcile net income to cash provided by operating activities: | ||||||||||||||||||||
| Depreciation and amortization |
|
|
||||||||||||||||||
| Amortization of deferred financing costs and original issue discount |
|
|
||||||||||||||||||
| Debt extinguishment and refinancing related costs |
|
|
||||||||||||||||||
| Deferred income taxes |
(
|
(
|
||||||||||||||||||
| Realized and unrealized foreign exchange losses, net |
|
|
||||||||||||||||||
| Stock-based compensation |
|
|
||||||||||||||||||
| Divestitures and impairment charges |
|
|
||||||||||||||||||
| Interest income on swaps designated as net investment hedges |
(
|
(
|
||||||||||||||||||
| Other non-cash, net |
|
(
|
||||||||||||||||||
| Changes in operating assets and liabilities: | ||||||||||||||||||||
| Trade accounts and notes receivable |
(
|
(
|
||||||||||||||||||
| Inventories |
|
(
|
||||||||||||||||||
| Prepaid expenses and other assets |
(
|
(
|
||||||||||||||||||
| Accounts payable |
|
|
||||||||||||||||||
| Other accrued liabilities |
(
|
|
||||||||||||||||||
| Other liabilities |
|
|
||||||||||||||||||
| Cash provided by operating activities |
|
|
||||||||||||||||||
| Investing activities: | ||||||||||||||||||||
| Acquisitions, net of cash acquired |
|
(
|
||||||||||||||||||
| Purchase of property, plant and equipment |
(
|
(
|
||||||||||||||||||
| Proceeds from sale of consolidated joint venture, net of cash divested |
|
|
||||||||||||||||||
| Interest proceeds on swaps designated as net investment hedges |
|
|
||||||||||||||||||
| Other investing activities, net |
|
(
|
||||||||||||||||||
| Cash used for investing activities |
(
|
(
|
||||||||||||||||||
| Financing activities: | ||||||||||||||||||||
| Proceeds from long-term borrowings |
|
|
||||||||||||||||||
| Payments on short-term borrowings |
(
|
(
|
||||||||||||||||||
| Payments on long-term borrowings |
(
|
(
|
||||||||||||||||||
| Financing-related costs |
(
|
(
|
||||||||||||||||||
| Purchases of common stock |
(
|
(
|
||||||||||||||||||
| Net cash flows associated with stock-based awards |
|
|
||||||||||||||||||
| Purchase of noncontrolling interests |
(
|
(
|
||||||||||||||||||
| Other financing activities, net |
|
(
|
||||||||||||||||||
| Cash provided by (used for) financing activities |
|
(
|
||||||||||||||||||
| Increase in cash |
|
|
||||||||||||||||||
| Effect of exchange rate changes on cash |
(
|
(
|
||||||||||||||||||
| Cash at beginning of period |
|
|
||||||||||||||||||
| Cash at end of period | $ |
|
$ |
|
||||||||||||||||
| Cash at end of period reconciliation: | ||||||||||||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
||||||||||||||||
| Restricted cash |
|
|
||||||||||||||||||
| Cash at end of period | $ |
|
$ |
|
||||||||||||||||
| Note | Page | |||||||
|
Performance
Coatings |
Transportation
Coatings |
Total | ||||||||||||||||||
| Balance at December 31, 2019 | $ |
|
$ |
|
$ |
|
||||||||||||||
| Foreign currency translation |
|
|
|
|||||||||||||||||
| Balance at September 30, 2020 | $ |
|
$ |
|
$ |
|
||||||||||||||
| September 30, 2020 |
Gross Carrying
Amount |
Accumulated
Amortization |
Net Book
Value |
Weighted Average
Amortization Periods (years) |
||||||||||||||||||||||
| Technology | $ |
|
$ |
(
|
$ |
|
|
|||||||||||||||||||
| Trademarks - indefinite-lived |
|
— |
|
Indefinite | ||||||||||||||||||||||
| Trademarks - definite-lived |
|
(
|
|
|
||||||||||||||||||||||
| Customer relationships |
|
(
|
|
|
||||||||||||||||||||||
| Other |
|
(
|
|
|
||||||||||||||||||||||
| Total | $ |
|
$ |
(
|
$ |
|
||||||||||||||||||||
| December 31, 2019 |
Gross Carrying
Amount |
Accumulated
Amortization |
Net Book
Value |
Weighted Average
Amortization Periods (years) |
||||||||||||||||||||||
| Technology | $ |
|
$ |
(
|
$ |
|
|
|||||||||||||||||||
| Trademarks—indefinite-lived |
|
— |
|
Indefinite | ||||||||||||||||||||||
| Trademarks—definite-lived |
|
(
|
|
|
||||||||||||||||||||||
| Customer relationships |
|
(
|
|
|
||||||||||||||||||||||
| Other |
|
(
|
|
|
||||||||||||||||||||||
| Total | $ |
|
$ |
(
|
$ |
|
||||||||||||||||||||
| Remainder of 2020 | $ |
|
||||||
| 2021 |
|
|||||||
| 2022 |
|
|||||||
| 2023 |
|
|||||||
| 2024 |
|
|||||||
| 2025 |
|
|||||||
| 2020 Activity | ||||||||
| Balance at December 31, 2019 | $ |
|
||||||
| Expenses, net of changes to estimates |
|
|||||||
| Payments made |
(
|
|||||||
| Foreign currency translation |
|
|||||||
| Balance at September 30, 2020 | $ |
|
||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | |||||||||||||||||||||||||||||||||||
|
Components of net periodic benefit cost:
|
||||||||||||||||||||||||||||||||||||||
| Net periodic benefit cost: | ||||||||||||||||||||||||||||||||||||||
| Service cost | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||
| Interest cost |
|
|
|
|
||||||||||||||||||||||||||||||||||
| Expected return on plan assets |
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||
| Amortization of actuarial loss, net |
|
|
|
|
||||||||||||||||||||||||||||||||||
| Plan curtailments, settlements and special termination benefits |
(
|
|
(
|
|
||||||||||||||||||||||||||||||||||
| Net periodic benefit cost | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||
| Stock Options |
Awards
(in millions) |
Weighted-
Average Exercise Price |
Aggregate
Intrinsic Value (in millions) |
Weighted
Average Remaining Contractual Life (years) |
||||||||||||||||||||||
| Outstanding at January 1, 2020 |
|
$ |
|
|||||||||||||||||||||||
| Granted |
|
$ |
|
|||||||||||||||||||||||
| Exercised |
(
|
$ |
|
|||||||||||||||||||||||
|
Forfeited
(1)
|
|
$ |
|
|||||||||||||||||||||||
| Outstanding at September 30, 2020 |
|
$ |
|
|||||||||||||||||||||||
| Vested and expected to vest at September 30, 2020 |
|
$ |
|
$ |
|
|
||||||||||||||||||||
| Exercisable at September 30, 2020 |
|
$ |
|
$ |
|
|
||||||||||||||||||||
| Restricted Stock Awards and Restricted Stock Units |
Awards/Units
(millions) |
Weighted-Average
Fair Value |
||||||||||||
| Outstanding at January 1, 2020 |
|
$ |
|
|||||||||||
| Granted |
|
$ |
|
|||||||||||
| Vested |
(
|
$ |
|
|||||||||||
| Forfeited |
(
|
$ |
|
|||||||||||
| Outstanding at September 30, 2020 |
|
$ |
|
|||||||||||
| Performance Stock Awards and Performance Share Units |
Awards/Units
(millions) |
Weighted-Average
Fair Value |
||||||||||||
| Outstanding at January 1, 2020 |
|
$ |
|
|||||||||||
| Granted |
|
$ |
|
|||||||||||
| Vested |
(
|
$ |
|
|||||||||||
| Forfeited |
(
|
$ |
|
|||||||||||
| Outstanding at September 30, 2020 |
|
$ |
|
|||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | |||||||||||||||||||||||||||||||||||
| Foreign exchange losses, net | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||
| Debt extinguishment and refinancing related costs |
|
|
|
|
||||||||||||||||||||||||||||||||||
| Other miscellaneous income, net |
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||
| Total | $ |
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||||||
| Nine Months Ended September 30, | ||||||||||||||||||||
| 2020 | 2019 | |||||||||||||||||||
| Effective Tax Rate |
(
|
% |
|
% | ||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||
| (In millions, except per share data) | 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||||||||||||||||
| Net income to common shareholders | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||
| Basic weighted average shares outstanding |
|
|
|
|
||||||||||||||||||||||||||||||||||
| Diluted weighted average shares outstanding |
|
|
|
|
||||||||||||||||||||||||||||||||||
| Net income per common share: | ||||||||||||||||||||||||||||||||||||||
| Basic net income per share | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||
| Diluted net income per share | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||
| September 30, 2020 | December 31, 2019 | |||||||||||||
|
Accounts receivable - trade, net
(1)
|
$ |
|
$ |
|
||||||||||
| Notes receivable |
|
|
||||||||||||
| Other |
|
|
||||||||||||
| Total | $ |
|
$ |
|
||||||||||
| September 30, 2020 | December 31, 2019 | |||||||||||||
| Finished products | $ |
|
$ |
|
||||||||||
| Semi-finished products |
|
|
||||||||||||
| Raw materials |
|
|
||||||||||||
| Stores and supplies |
|
|
||||||||||||
| Total | $ |
|
$ |
|
||||||||||
| September 30, 2020 | December 31, 2019 | |||||||||||||
| Property, plant and equipment | $ |
|
$ |
|
||||||||||
| Accumulated depreciation |
(
|
(
|
||||||||||||
| Property, plant, and equipment, net | $ |
|
$ |
|
||||||||||
| September 30, 2020 | December 31, 2019 | |||||||||||||
| 2024 Dollar Term Loans | $ |
|
$ |
|
||||||||||
| 2024 Dollar Senior Notes |
|
|
||||||||||||
| 2024 Euro Senior Notes |
|
|
||||||||||||
| 2025 Euro Senior Notes |
|
|
||||||||||||
| 2027 Dollar Senior Notes |
|
|
||||||||||||
| Short-term and other borrowings |
|
|
||||||||||||
| Unamortized original issue discount |
(
|
(
|
||||||||||||
| Unamortized deferred financing costs |
(
|
(
|
||||||||||||
| Total borrowings, net |
|
|
||||||||||||
| Less: | ||||||||||||||
| Short-term borrowings |
|
|
||||||||||||
| Current portion of long-term borrowings |
|
|
||||||||||||
| Long-term debt | $ |
|
$ |
|
||||||||||
| Period | 2027 Senior Notes Percentage | |||||||
| 2023 |
|
% | ||||||
| 2024 |
|
% | ||||||
| 2025 and thereafter |
|
% | ||||||
| Remainder of 2020 | $ |
|
||||||
| 2021 |
|
|||||||
| 2022 |
|
|||||||
| 2023 |
|
|||||||
| 2024 |
|
|||||||
| Thereafter |
|
|||||||
| Total borrowings |
|
|||||||
| Unamortized original issue discount |
(
|
|||||||
| Unamortized deferred financing costs |
(
|
|||||||
| Total borrowings, net | $ |
|
||||||
| September 30, 2020 | December 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Prepaid expenses and other current assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Cross-currency swaps
(2)
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Foreign currency forward contracts
(1)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Cross-currency swaps
(2)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Investments in equity securities
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other accrued liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Interest rate caps
(1)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Interest rate swaps
(1)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Interest rate caps
(1)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Interest rate swaps
(1)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Cross-currency swaps
(2)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Long-term borrowings: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
2024 Dollar Term Loans
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
2024 Dollar Senior Notes
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
2024 Euro Senior Notes
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
2025 Euro Senior Notes
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
2027 Dollar Senior Notes
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| September 30, 2020 | December 31, 2019 | |||||||||||||
| AOCI: | ||||||||||||||
| Interest rate caps (cash flow hedges) | $ |
|
$ |
|
||||||||||
| Interest rate swaps (cash flow hedges) |
|
|
||||||||||||
| Foreign currency forward contracts (cash flow hedges) |
|
|
||||||||||||
| Cross-currency swaps (net investment hedges) |
(
|
(
|
||||||||||||
| Total AOCI | $ |
|
$ |
|
||||||||||
| For the Three Months Ended September 30, | ||||||||||||||||||||||||||||||||||||||||||||||||||
| 2020 | 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Derivatives in Cash Flow and Net Investment Hedges | Location of Loss Recognized in Income on Derivatives | Net Amount of Loss Recognized in OCI on Derivatives | Amount of Loss (Gain) Recognized in Income | Net Amount of Loss (Gain) Recognized in OCI on Derivatives | Amount of (Gain) Loss Recognized in Income | |||||||||||||||||||||||||||||||||||||||||||||
| Interest rate caps | Interest expense, net | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||||||||||||
| Interest rate swaps | Interest expense, net |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency forward contracts | Cost of goods sold |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Cross-currency swaps
|
Interest expense, net |
|
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
| For the Nine Months Ended September 30, | ||||||||||||||||||||||||||||||||||||||||||||||||||
| 2020 | 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Derivatives in Cash Flow and Net Investment Hedges | Location of Loss (Gain) Recognized in Income on Derivatives | Net Amount of Loss (Gain) Recognized in OCI on Derivatives | Amount of Loss (Gain) Recognized in Income | Net Amount of Loss (Gain) Recognized in OCI on Derivatives | Amount of (Gain) Loss Recognized in Income | |||||||||||||||||||||||||||||||||||||||||||||
| Interest rate caps | Interest expense, net | $ |
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||||||||||||||||||||||||||||
| Interest rate swaps | Interest expense, net |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency forward contracts | Cost of goods sold |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Cross-currency swaps
|
Interest expense, net |
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
|
Derivatives Not Designated as Hedging
Instruments under ASC 815 |
Location of Loss (Gain) Recognized in
Income on Derivatives |
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | |||||||||||||||||||||||||||||||||||||||||
| Foreign currency forward contracts | Other income, net | $ |
(
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | |||||||||||||||||||||||||||||||||||
|
Net sales
(1)
:
|
||||||||||||||||||||||||||||||||||||||
| Refinish | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||
| Industrial |
|
|
|
|
||||||||||||||||||||||||||||||||||
| Total Net sales Performance Coatings |
|
|
|
|
||||||||||||||||||||||||||||||||||
| Light Vehicle |
|
|
|
|
||||||||||||||||||||||||||||||||||
| Commercial Vehicle |
|
|
|
|
||||||||||||||||||||||||||||||||||
| Total Net sales Transportation Coatings |
|
|
|
|
||||||||||||||||||||||||||||||||||
| Total Net sales | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||
| Equity in earnings in unconsolidated affiliates: | ||||||||||||||||||||||||||||||||||||||
| Performance Coatings | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||
| Transportation Coatings |
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||
| Total | $ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||
|
September 30,
2020 |
December 31,
2019 |
|||||||||||||||||||||||||||||||||||||
| Investment in unconsolidated affiliates: | ||||||||||||||||||||||||||||||||||||||
| Performance Coatings | $ |
|
$ |
|
||||||||||||||||||||||||||||||||||
| Transportation Coatings |
|
|
||||||||||||||||||||||||||||||||||||
| Total | $ |
|
$ |
|
||||||||||||||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | |||||||||||||||||||||||||||||||||||
|
Segment Adjusted EBIT
(1)
:
|
||||||||||||||||||||||||||||||||||||||
| Performance Coatings | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||
| Transportation Coatings |
|
|
|
|
||||||||||||||||||||||||||||||||||
|
Total
(2)
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Interest expense, net |
|
|
|
|
||||||||||||||||||||||||||||||||||
|
Debt extinguishment and refinancing related costs
(a)
|
|
|
|
|
||||||||||||||||||||||||||||||||||
|
Termination benefits and other employee related costs
(b)
|
|
|
|
|
||||||||||||||||||||||||||||||||||
|
Strategic review and retention costs
(c)
|
|
|
|
|
||||||||||||||||||||||||||||||||||
|
Offering and transactional costs
(d)
|
|
|
|
|
||||||||||||||||||||||||||||||||||
|
Loss (gain) on divestiture and impairments
(e)
|
|
(
|
|
|
||||||||||||||||||||||||||||||||||
|
Pension special events
(f)
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||||
|
Accelerated depreciation
(g)
|
|
|
|
|
||||||||||||||||||||||||||||||||||
|
Indemnity loss (income)
(h)
|
|
|
|
(
|
||||||||||||||||||||||||||||||||||
| Income before income taxes | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||
| (1) |
The primary measure of segment operating performance is Adjusted EBIT, which is defined as net income before interest, taxes and select other items impacting operating results. These other items impacting operating results are items that management has concluded are (1) non-cash items included within net income, (2) items the Company does not believe are indicative of ongoing operating performance or (3) non-recurring, unusual or infrequent items that have not occurred within the last two years or we believe are not reasonably likely to recur within the next two years. Adjusted EBIT is a key metric that is used by management to evaluate business performance in comparison to budgets, forecasts and prior year financial results, providing a measure that management believes reflects the Company’s core operating performance, which represents Adjusted EBIT adjusted for the select items referred to above.
|
||||
| (2) |
Does not represent Axalta’s Adjusted EBIT referenced elsewhere by the Company as there are additional adjustments that are not allocated to the segments.
|
||||
| (a) | Represents expenses and associated changes to estimates related to the prepayment, restructuring, and refinancing of our indebtedness, which are not considered indicative of our ongoing operating performance. | ||||
| (b) | Represents expenses and associated changes to estimates related to employee termination benefits and other employee-related costs. Employee termination benefits are primarily associated with Axalta Way initiatives. These amounts are not considered indicative of our ongoing operating performance. | ||||
| (c) |
Represents costs for legal, tax and other advisory fees pertaining to our review of strategic alternatives that was concluded in March 2020, as well as retention awards for certain employees which will be earned over a period of
|
||||
| (d) | Represents acquisition and divestiture-related expenses, all of which are not considered indicative of our ongoing operating performance. | ||||
| (e) | Represents expenses and associated changes to estimates related to the sale of our interest in a joint venture business and other impairments, which are not considered indicative of our ongoing operating performance. | ||||
| (f) | Represents certain defined benefit pension costs associated with special events, including pension curtailments, settlements and special termination benefits, which we do not consider indicative of our ongoing operating performance. | ||||
| (g) | Represents incremental depreciation expense resulting from truncated useful lives of the assets impacted by our manufacturing footprint assessments, which we do not consider indicative of our ongoing operating performance. | ||||
| (h) | Represents indemnity loss (income) associated with the acquisition by Axalta of the DuPont Performance Coatings business, which we do not consider indicative of our ongoing operating performance. | ||||
|
Unrealized
Currency Translation Adjustments |
Pension
Adjustments |
Unrealized
(Loss) Gain on Derivatives |
Accumulated
Other Comprehensive (Loss) Income |
|||||||||||||||||||||||
| Balance at December 31, 2019 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
| Current year deferrals to AOCI |
(
|
|
(
|
(
|
||||||||||||||||||||||
|
Reclassifications from AOCI to Net income
|
|
(
|
|
|
||||||||||||||||||||||
| Net Change |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Balance at March 31, 2020 |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Current year deferrals to AOCI |
|
|
(
|
|
||||||||||||||||||||||
|
Reclassifications from AOCI to Net income
|
|
|
|
|
||||||||||||||||||||||
| Net Change |
|
|
(
|
|
||||||||||||||||||||||
| Balance at June 30, 2020 |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Current year deferrals to AOCI |
|
(
|
(
|
|
||||||||||||||||||||||
|
Reclassifications from AOCI to Net income
|
|
(
|
|
|
||||||||||||||||||||||
| Net Change |
|
(
|
|
|
||||||||||||||||||||||
| Balance at September 30, 2020 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
|
Unrealized
Currency Translation Adjustments |
Pension
Adjustments |
Unrealized
Gain (Loss) on Derivatives |
Accumulated
Other Comprehensive Income (Loss) |
|||||||||||||||||||||||
| Balance at December 31, 2018 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
| Current year deferrals to AOCI |
|
|
(
|
|
||||||||||||||||||||||
|
Reclassifications from AOCI to Net income
|
|
|
(
|
(
|
||||||||||||||||||||||
| Net Change |
|
|
(
|
|
||||||||||||||||||||||
| Balance at March 31, 2019 |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Current year deferrals to AOCI |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
|
Reclassifications from AOCI to Net income
|
|
|
(
|
|
||||||||||||||||||||||
| Net Change |
(
|
|
(
|
(
|
||||||||||||||||||||||
| Balance at June 30, 2019 |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Current year deferrals to AOCI |
(
|
|
(
|
(
|
||||||||||||||||||||||
|
Reclassifications from AOCI to Net income
|
|
|
|
|
||||||||||||||||||||||
| Net Change |
(
|
|
(
|
(
|
||||||||||||||||||||||
| Balance at September 30, 2019 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
| (In millions) | Three Months Ended September 30, | 2020 vs 2019 | Nine Months Ended September 30, | 2020 vs 2019 | ||||||||||||||||||||||||||||||||||||||||||||||
| 2020 | 2019 | % change | 2020 | 2019 | % change | |||||||||||||||||||||||||||||||||||||||||||||
| Performance Coatings | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinish | $ | 401.7 | $ | 441.5 | (9.0) | % | $ | 1,031.4 | $ | 1,294.3 | (20.3) | % | ||||||||||||||||||||||||||||||||||||||
| Industrial | 281.0 | 282.2 | (0.4) | % | 781.1 | 899.4 | (13.2) | % | ||||||||||||||||||||||||||||||||||||||||||
| Total Net sales Performance Coatings | 682.7 | 723.7 | (5.7) | % | 1,812.5 | 2,193.7 | (17.4) | % | ||||||||||||||||||||||||||||||||||||||||||
| Transportation Coatings | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Light Vehicle | 276.3 | 295.7 | (6.6) | % | 662.7 | 917.7 | (27.8) | % | ||||||||||||||||||||||||||||||||||||||||||
| Commercial Vehicle | 67.9 | 87.6 | (22.5) | % | 187.9 | 272.4 | (31.0) | % | ||||||||||||||||||||||||||||||||||||||||||
| Total Net sales Transportation Coatings | 344.2 | 383.3 | (10.2) | % | 850.6 | 1,190.1 | (28.5) | % | ||||||||||||||||||||||||||||||||||||||||||
| Total Net sales | $ | 1,026.9 | $ | 1,107.0 | (7.2) | % | $ | 2,663.1 | $ | 3,383.8 | (21.3) | % | ||||||||||||||||||||||||||||||||||||||
| Three Months Ended September 30, | 2020 vs 2019 | Nine Months Ended September 30, | 2020 vs 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2020 | 2019 | $ Change | % Change | 2020 | 2019 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Net sales
|
$ | 1,026.9 | $ | 1,107.0 | $ | (80.1) | (7.2) | % | $ | 2,663.1 | $ | 3,383.8 | $ | (720.7) | (21.3) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Volume effect
|
(6.0) | % | (18.8) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Impact of portfolio changes
|
0.1 | % | (0.8) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Price/product mix effect
|
(1.4) | % | (0.1) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Exchange rate effect
|
0.1 | % | (1.6) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Net sales decreased due to the following:
|
||
|
n
Lower sales volumes across both segments and all regions driven by significantly reduced global automotive production, lower vehicle miles driven and accelerated industrial slowdown primarily as a result of COVID-19 impacts, as well as previously anticipated muted industrial trends and declines in light and commercial vehicle builds
|
||
|
n
Lower average selling prices and product mix resulting primarily from a change in product mix in refinish, partially offset by an increase in commercial vehicle
|
||
|
Partially offset by:
|
||
|
n
Favorable impacts of currency translation, due primarily to the strengthening of the Euro and Chinese Renminbi compared to the U.S. dollar
|
||
|
Net sales decreased due to the following:
|
||
|
n
Lower sales volumes across both segments and all regions driven by significantly reduced global automotive production, lower vehicle miles driven and accelerated industrial slowdown primarily as a result of COVID-19 impacts, as well as previously anticipated muted industrial trends and declines in light and commercial vehicle builds
|
||
|
n
Unfavorable impacts of currency translation, due primarily to the weakening of the Euro, Chinese Renminbi, Brazilian Real, and Mexican Peso compared to the U.S. dollar
|
||
|
n
Negative impacts as a result of portfolio changes resulting from the sale of our consolidated joint venture interests within our Performance Coatings segment during the second quarter of 2019
|
||
|
n
Lower average selling prices and product mix resulting primarily from a change in product mix in refinish, mostly offset by an increase across both end-markets and all regions within the Transportation Coatings segment, primarily within light vehicle
|
||
| Three Months Ended September 30, | 2020 vs 2019 | Nine Months Ended September 30, | 2020 vs 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2020 | 2019 | $ Change | % Change | 2020 | 2019 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cost of sales | $ | 634.1 | $ | 707.4 | $ | (73.3) | (10.4) | % | $ | 1,780.1 | $ | 2,207.1 | $ | (427.0) | (19.3) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
% of net sales
|
61.7 | % | 63.9 | % | 66.8 | % | 65.2 | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Cost of sales decreased due to the following:
|
||
|
n
Lower sales volumes across both segments and all regions
|
||
|
n
Decline in depreciation expense for operating equipment
|
||
|
n
Decreased variable input costs across both segments
|
||
|
n
Reduction in costs due to operational efficiencies associated with our cost savings initiatives, including decreased compensation related expenses associated with COVID-19 related cost reduction actions
|
||
|
Partially offset by:
|
||
|
n
Unfavorable impacts of currency translation of 0.5%, due primarily to the strengthening of the Euro and Chinese Renminbi compared to the U.S. dollar
|
||
|
Cost of sales as a percentage of net sales decreased due to the following:
|
||
|
n
Decreases associated with lower variable input costs and operational efficiencies associated with cost savings initiatives, including decreased compensation related expenses associated with COVID-19 related cost reduction actions
|
||
|
Partially offset by:
|
||
|
n
Decreased net sales from price and product mix, primarily resulting from impacts of product mix sold in refinish
|
||
|
Cost of sales decreased due to the following:
|
||
|
n
Lower sales volumes across both segments and all regions
|
||
|
n
Lower costs as a result of portfolio changes resulting from the sale of our consolidated joint venture interests within our Performance Coatings segment during the second quarter of 2019
|
||
|
n
Decline in depreciation expense for operating equipment
|
||
|
n
Decreased variable input costs across both segments and all regions
|
||
|
n
Reduction in costs due to operational efficiencies associated with our cost savings initiatives, including decreased compensation related expenses associated with COVID-19 related cost reduction actions
|
||
|
Partially offset by:
|
||
|
n
Increased expenses associated with reduced utilization at certain manufacturing sites and increased inventory reserves
|
||
|
n
Unfavorable impacts of currency translation, due primarily to the weakening of the Euro, Chinese Renminbi, Brazilian Real, and Mexican Peso compared to the U.S. dollar
|
||
|
Cost of sales as a percentage of net sales increased due to the following:
|
||
|
n
Lower sales volume covering fixed costs, including impacts of reduced utilization at certain manufacturing sites and increased inventory reserves
|
||
|
Partially offset by:
|
||
|
n
Decreases associated with variable cost savings and operational efficiencies associated with cost savings initiatives, including decreased compensation related expenses associated with COVID-19 related cost reduction actions
|
||
| Three Months Ended September 30, | 2020 vs 2019 | Nine Months Ended September 30, | 2020 vs 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2020 | 2019 | $ Change | % Change | 2020 | 2019 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
SG&A
|
$ | 166.5 | $ | 199.2 | $ | (32.7) | (16.4) | % | $ | 516.1 | $ | 617.2 | $ | (101.1) | (16.4) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Selling, general and administrative expenses decreased due to the following:
|
||
|
n
Reduction in costs due to operational efficiencies associated with our cost savings initiatives, including decreased compensation-related expenses associated with COVID-19 related cost reduction actions
|
||
|
n
Decline in commissions and sales incentive compensation driven by decrease in net sales
|
||
|
Partially offset by:
|
||
|
n
Unfavorable impacts of currency translation of 1.0%, due primarily to the strengthening of the Euro and Chinese Renminbi compared to the U.S. dollar
|
||
|
Selling, general and administrative expenses decreased due to the following:
|
||
|
n
Reduction in costs due to operational efficiencies associated with our cost savings initiatives, including decreased compensation-related expenses associated with COVID-19 related cost reduction actions
|
||
|
n
Decline in commissions and sales incentive compensation driven by decrease in net sales
|
||
|
n
Lower costs as a result of portfolio changes resulting from the sale of our consolidated joint venture interests within our Performance Coatings segment during the second quarter of 2019
|
||
|
n
Favorable impacts of currency translation of 2.1%, due primarily to the weakening of the Euro, Chinese Renminbi, and Brazilian Real compared to the U.S. dollar
|
||
|
Partially offset by:
|
||
|
n
Increased reserves for trade receivables of $9.1 million to $12.8 million from $3.7 million in the prior year
|
||
|
n
Increased stock-based compensation expenses of $6.4 million, primarily due to forfeitures in the prior year
|
||
| Three Months Ended September 30, | 2020 vs 2019 | Nine Months Ended September 30, | 2020 vs 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2020 | 2019 | $ Change | % Change | 2020 | 2019 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Other operating charges
|
$ | 42.6 | $ | 31.8 | $ | 10.8 | 34.0 | % | $ | 98.9 | $ | 41.4 | $ | 57.5 | 138.9 | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Other operating charges increased due to the following:
|
||
|
n
Increase in termination benefits and other employee related costs associated with our cost savings initiatives of $6.5 million from $29.2 million in the prior year to $35.7 million in the current year
|
||
|
n
Increased expenses of $3.9 million associated with the review of strategic alternatives that was concluded in March 2020 as discussed above within "Business Highlights - Strategic Review" and retention costs from $3.0 million in the prior year to $6.9 million in the current year
|
||
|
Other operating charges increased due to the following:
|
||
|
n
Increase in termination benefits and other employee related costs associated with our cost saving initiatives of $37.1 million from $33.3 million in the prior year to $70.4 million in the current year
|
||
|
n
Increased expenses of $21.3 million associated with the review of strategic alternatives that was concluded in March 2020 as discussed above within "Business Highlights - Strategic Review" and retention costs from $3.8 million in the prior year to $25.1 million in the current year
|
||
| Three Months Ended September 30, | 2020 vs 2019 | Nine Months Ended September 30, | 2020 vs 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2020 | 2019 | $ Change | % Change | 2020 | 2019 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Research and development expenses
|
$ | 13.4 | $ | 17.4 | $ | (4.0) | (23.0) | % | $ | 41.2 | $ | 53.5 | $ | (12.3) | (23.0) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Research and development expenses decreased due to the following:
|
||
|
n
Decrease in operating expenses as a result of operational efficiencies associated with cost savings initiatives, as well as decreased compensation-related expenses associated with COVID-19 related cost reduction actions
|
||
|
Partially offset by:
|
||
|
n
Unfavorable impacts of currency translation, which increased expenses by 0.3%, due primarily to the strengthening of the Euro and Chinese Renminbi compared to the U.S. dollar
|
||
|
Research and development expenses decreased due to the following:
|
||
|
n
Decrease in operating expenses as a result of operational efficiencies associated with cost savings initiatives, including decreased compensation-related expenses associated with COVID-19 related cost reduction actions
|
||
|
n
Favorable impacts of currency translation, which reduced expenses by 0.5%, due primarily to the weakening of the Euro compared to the U.S. dollar
|
||
| Three Months Ended September 30, | 2020 vs 2019 | Nine Months Ended September 30, | 2020 vs 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2020 | 2019 | $ Change | % Change | 2020 | 2019 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Amortization of acquired intangibles
|
$ | 28.6 | $ | 28.2 | $ | 0.4 | 1.4 | % | $ | 84.5 | $ | 85.1 | $ | (0.6) | (0.7) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Amortization of acquired intangibles increased due to the following:
|
||
|
n
Unfavorable impacts of foreign currency translation, primarily related to the strengthening of the Euro compared to the U.S. dollar
|
||
|
Amortization of acquired intangibles decreased due to the following:
|
||
|
n
Favorable impacts of foreign currency translation, primarily related to the weakening of the Euro compared to the U.S. dollar
|
||
| Three Months Ended September 30, | 2020 vs 2019 | Nine Months Ended September 30, | 2020 vs 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2020 | 2019 | $ Change | % Change | 2020 | 2019 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest expense, net | $ | 39.8 | $ | 40.2 | $ | (0.4) | (1.0) | % | $ | 112.4 | $ | 122.5 | $ | (10.1) | (8.2) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Interest expense, net decreased primarily due to the following:
|
||
|
n
Decrease in principal base due to the voluntary prepayment of $300.0 million on our 2024 Dollar Term Loans in January 2020
|
||
|
n
Decrease in average interest rates due to LIBOR decreases on our variable rate debt over the comparable period
|
||
|
Partially offset by:
|
||
|
n
Increase in expense associated with the issuance of $500.0 million aggregate principal amount of 2027 Senior Notes
|
||
|
n
Unfavorable impacts of our derivative instruments
|
||
|
n
Strengthening of the Euro compared to the U.S. dollar
|
||
|
Interest expense, net decreased primarily due to the following:
|
||
|
n
Decrease in principal base due to the voluntary prepayment of $300.0 million on our 2024 Dollar Term Loans in January 2020
|
||
|
n
Decrease in average interest rates due to LIBOR decreases on our variable rate debt over the comparable period
|
||
|
Partially offset by:
|
||
|
n
Increase from expense associated with the issuance of $500.0 million aggregate principal amount of 2027 Senior Notes
|
||
|
n
Unfavorable impacts of our derivative instruments
|
||
| Three Months Ended September 30, | 2020 vs 2019 | Nine Months Ended September 30, | 2020 vs 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2020 | 2019 | $ Change | % Change | 2020 | 2019 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other expense (income), net | $ | 2.3 | $ | (1.9) | $ | 4.2 | 221.1 | % | $ | 0.9 | $ | (3.8) | $ | 4.7 | 123.7 | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Other expense (income), net increased due to the following:
|
||
|
n
Increased impact of foreign exchange losses of $4.8 million from $0.7 million during the prior period to $5.5 million during the current period due to strengthening of Euro
|
||
|
Partially offset by:
|
||
|
n
Net benefits of $0.7 million resulting from pension curtailments and settlements released from accumulated other comprehensive loss, partially offset by special termination benefits
|
||
|
n
Increase in miscellaneous income
|
||
|
Other expense (income), net increased due to the following:
|
||
|
n
Debt extinguishment and refinancing related costs of $2.4 million, driven primarily by the write off of unamortized deferred financing costs and original issue discounts in relation with the voluntary prepayment of $300.0 million of outstanding principal on our 2024 Dollar Term Loans in January 2020
|
||
|
n
Increased impact of foreign exchange losses of $2.2 million from $5.3 million during the prior period to $7.5 million during the current period due to Euro exposure
|
||
|
n
Decrease in miscellaneous income
|
||
|
Partially offset by:
|
||
|
n
Net benefits of $2.5 million during the current period resulting from pension curtailments and settlements released from accumulated other comprehensive loss, partially offset by special termination benefits
|
||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | |||||||||||||||||||||||||||||||||||
| Income before income taxes | $ | 99.6 | $ | 84.7 | $ | 29.0 | $ | 260.8 | ||||||||||||||||||||||||||||||
| Provision (benefit) for income taxes | 17.1 | 18.3 | (22.7) | 50.4 | ||||||||||||||||||||||||||||||||||
|
Statutory U.S. Federal income tax rate
|
21.0 | % | 21.0 | % | 21.0 | % | 21.0 | % | ||||||||||||||||||||||||||||||
|
Effective tax rate
|
17.2 | % | 21.6 | % | (78.3) | % | 19.3 | % | ||||||||||||||||||||||||||||||
| Effective tax rate vs. statutory U.S. Federal income tax rate | (3.8) | % | 0.6 | % | (99.3) | % | (1.7) | % | ||||||||||||||||||||||||||||||
| (Favorable) Unfavorable Impact | ||||||||||||||||||||||||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||||||||
|
Items impacting the effective tax rate vs. statutory U.S. federal income tax rate
|
2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||||||||||||||||||||||
|
Earnings generated in jurisdictions where the statutory rate is different from the U.S. Federal rate
(1)
|
$ | (7.0) | $ | (5.5) | $ | (12.9) | $ | (16.5) | ||||||||||||||||||||||||||||||||||||
|
Changes in valuation allowance
|
(1.4) | 5.6 | 6.0 | (13.6) | ||||||||||||||||||||||||||||||||||||||||
| Foreign exchange gain (loss), net | 2.4 | (1.3) | 1.1 | (0.4) | ||||||||||||||||||||||||||||||||||||||||
|
Stock-based compensation excess tax benefits, net
|
— | (4.2) | — | (11.0) | ||||||||||||||||||||||||||||||||||||||||
|
Non-deductible expenses and interest
|
0.9 | 1.1 | 4.0 | 3.3 | ||||||||||||||||||||||||||||||||||||||||
|
Increase in unrecognized tax benefits
(2)
|
1.8 | 2.0 | 21.1 | 9.2 | ||||||||||||||||||||||||||||||||||||||||
|
Intra-entity asset transfer
(3)
|
— | — | (50.5) | — | ||||||||||||||||||||||||||||||||||||||||
|
Foreign taxes
(4)
|
0.9 | 0.3 | 4.4 | 18.7 | ||||||||||||||||||||||||||||||||||||||||
| Three Months Ended September 30, | 2020 vs 2019 | Nine Months Ended September 30, | 2020 vs 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2020 | 2019 | $ Change | % Change | 2020 | 2019 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Net sales
|
$ | 682.7 | $ | 723.7 | $ | (41.0) | (5.7) | % | $ | 1,812.5 | $ | 2,193.7 | $ | (381.2) | (17.4) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Volume effect
|
(4.5) | % | (14.1) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Impact of portfolio changes
|
0.1 | % | (1.3) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Price/product mix effect
|
(2.4) | % | (0.9) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Exchange rate effect
|
1.1 | % | (1.1) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted EBIT | $ | 133.9 | $ | 124.9 | $ | 9.0 | 7.2 | % | $ | 214.8 | $ | 331.1 | $ | (116.3) | (35.1) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Adjusted EBIT Margin
|
19.6 | % | 17.3 | % | 11.9 | % | 15.1 | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Net sales decreased due to the following:
|
||
|
n
Lower organic refinish volumes across all regions due to decreased demand primarily as a result of lower vehicle miles driven due to COVID-19
|
||
|
n
Lower average selling prices and product mix across both end-markets, primarily driven by a change in product mix sold in refinish
|
||
|
Partially offset by:
|
||
|
n
Favorable impacts of currency translation, due primarily to the strengthening of the Euro compared to the U.S. dollar
|
||
|
Adjusted EBIT increased due to the following:
|
||
|
n
Lower operating expenses across both end-markets resulting from operational efficiencies associated with our cost savings initiatives including lower compensation expense associated with COVID-19 related cost reduction actions and decreased costs to support net sales
|
||
|
n
Lower variable input costs across both end-markets
|
||
|
Partially offset by:
|
||
|
n
Lower organic volumes across all regions driven by refinish, due to decreased demand primarily as a result of lower vehicle miles driven due to COVID-19
|
||
|
n
Lower average selling prices and product mix across both end-markets
|
||
|
n
Unfavorable impacts of currency translation, due primarily to the weakening of the Brazilian Real and Mexican Peso compared to the U.S. dollar
|
||
|
Net sales decreased due to the following:
|
||
|
n
Lower organic volumes across both end-markets and all regions due to decreased demand primarily as a result of lower vehicle miles driven and industrial production due to COVID-19
|
||
|
n
Unfavorable impacts of currency translation, due primarily to the weakening of the Euro, Chinese Renminbi, Brazilian Real and Mexican Peso compared to the U.S. dollar
|
||
|
n
Negative impacts as a result of portfolio changes within our industrial end-market, which included the sale of our consolidated joint venture interests during the second quarter of 2019
|
||
|
n
Lower average selling prices and product mix across both end-markets, primarily driven by a change in product mix sold in refinish
|
||
|
Adjusted EBIT decreased due to the following:
|
||
|
n
Lower organic volumes across both end-markets and all regions due to decreased demand primarily as a result of lower vehicle miles driven due to COVID-19
|
||
|
n
Lower average selling prices and product mix across both end-markets
|
||
|
n
Unfavorable impacts of currency translation, due primarily to the weakening of the Euro, Chinese Renminbi, Brazilian Real and Mexican Peso compared to the U.S. dollar
|
||
|
n
Lower sales volume covering fixed costs, including impacts of reduced utilization at certain manufacturing sites and increased inventory reserves
|
||
|
Partially offset by:
|
||
|
n
Lower operating expenses across both end-markets and most regions, resulting from operational efficiencies associated with our cost savings initiatives including lower compensation expense associated with COVID-19 related cost reduction actions and decreased costs to support net sales
|
||
|
n
Lower variable input costs across both end-markets and all regions
|
||
| Three Months Ended September 30, | 2020 vs 2019 | Nine Months Ended September 30, | 2020 vs 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2020 | 2019 | $ Change | % Change | 2020 | 2019 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net sales | $ | 344.2 | $ | 383.3 | $ | (39.1) | (10.2) | % | $ | 850.6 | $ | 1,190.1 | $ | (339.5) | (28.5) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Volume effect | (9.0) | % | (27.3) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Price/product mix effect | 0.4 | % | 1.5 | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Exchange rate effect | (1.6) | % | (2.7) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted EBIT | $ | 48.5 | $ | 37.2 | $ | 11.3 | 30.4 | % | $ | 35.0 | $ | 111.8 | $ | (76.8) | (68.7) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted EBIT Margin | 14.1 | % | 9.7 | % | 4.1 | % | 9.4 | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Net sales decreased due to the following:
|
||
|
n
Lower organic volumes across both end-markets and all regions due to decreased demand primarily as a result of significantly reduced global automotive production due to COVID-19 as well as a previously anticipated decrease in vehicle builds
|
||
|
n
Unfavorable impacts of currency translation, due primarily to the weakening of the Brazilian Real and South African Rand compared to the U.S. dollar
|
||
|
Partially offset by:
|
||
|
n
Higher average selling prices across most regions driven by commercial vehicle
|
||
|
Adjusted EBIT increased due to the following:
|
||
|
n
Lower operating expenses across both end-markets and all regions, primarily in light vehicle resulting from operational efficiencies associated with our cost savings initiatives including lower compensation expense associated with COVID-19 related cost reduction actions and decreased costs to support net sales
|
||
|
n
Lower variable input costs across both end-markets and all regions
|
||
|
n
Higher average selling prices across most regions driven by commercial vehicle
|
||
|
Partially offset by:
|
||
|
n
Lower organic volumes across both end-markets and all regions due to decreased demand primarily as a result of significantly reduced global automotive production due to COVID-19 as well as a previously anticipated decrease in vehicle builds
|
||
|
n
Unfavorable impacts of currency translation, due primarily to the weakening of the Brazilian Real and South African Rand compared to the U.S. dollar
|
||
|
Net sales decreased due to the following:
|
||
|
n
Lower organic volumes across both end-markets and all regions due to decreased demand primarily as a result of significantly reduced global automotive production due to COVID-19 as well as a previously anticipated decrease in vehicle builds
|
||
|
n
Unfavorable impacts of currency translation, due primarily to the weakening of the Brazilian Real, Mexican Peso, Euro and Chinese Renminbi compared to the U.S. dollar
|
||
|
Partially offset by:
|
||
|
n
Higher average selling prices across both end-markets and all regions
|
||
|
Adjusted EBIT decreased due to the following:
|
||
|
n
Lower organic volumes across both end-markets and all regions due to decreased demand primarily as a result of significantly reduced global automotive production due to COVID-19 as well as a previously anticipated decrease in vehicle builds
|
||
|
n
Unfavorable impacts of currency translation, due primarily to the weakening of the Brazilian Real, Mexican Peso, Euro and Chinese Renminbi compared to the U.S. dollar
|
||
|
n
Lower sales volume covering fixed costs, including impacts of reduced utilization at certain manufacturing sites and increased inventory reserves
|
||
|
Partially offset by:
|
||
|
n
Lower operating expenses across both end-markets and most regions, resulting from operational efficiencies associated with our cost savings initiatives including lower compensation expense associated with COVID-19 related cost reduction actions and costs to decreased support net sales
|
||
|
n
Higher average selling prices across both end-markets and all regions
|
||
|
n
Lower variable input costs across both end-markets and all regions
|
||
| Nine Months Ended September 30, | ||||||||||||||||||||
| (In millions) | 2020 | 2019 | ||||||||||||||||||
| Net cash provided by (used for): | ||||||||||||||||||||
| Operating activities: | ||||||||||||||||||||
| Net income | $ | 51.7 | $ | 210.4 | ||||||||||||||||
| Depreciation and amortization | 243.6 | 267.3 | ||||||||||||||||||
| Amortization of deferred financing costs and original issue discount | 6.8 | 6.7 | ||||||||||||||||||
| Debt extinguishment and refinancing related costs | 2.4 | 0.2 | ||||||||||||||||||
| Deferred income taxes | (57.2) | (5.6) | ||||||||||||||||||
| Realized and unrealized foreign exchange losses, net | 12.7 | 1.5 | ||||||||||||||||||
| Stock-based compensation | 15.9 | 9.5 | ||||||||||||||||||
| Divestitures and impairment charges | 3.5 | 3.4 | ||||||||||||||||||
| Interest income on swaps designated as net investment hedges | (11.0) | (11.0) | ||||||||||||||||||
| Other non-cash, net | 2.7 | (3.5) | ||||||||||||||||||
| Net income adjusted for non-cash items | 271.1 | 478.9 | ||||||||||||||||||
| Changes in operating assets and liabilities | (40.2) | (189.1) | ||||||||||||||||||
| Operating activities | 230.9 | 289.8 | ||||||||||||||||||
| Investing activities | (39.3) | (59.0) | ||||||||||||||||||
| Financing activities | 136.8 | (145.0) | ||||||||||||||||||
| Effect of exchange rate changes on cash | (4.7) | (12.1) | ||||||||||||||||||
| Net increase in cash, cash equivalents and restricted cash | $ | 323.7 | $ | 73.7 | ||||||||||||||||
| (In millions) | September 30, 2020 | December 31, 2019 | ||||||||||||
| 2024 Dollar Term Loans | $ | 2,069.3 | $ | 2,387.5 | ||||||||||
| 2024 Dollar Senior Notes | 500.0 | 500.0 | ||||||||||||
| 2024 Euro Senior Notes | 391.4 | 375.2 | ||||||||||||
| 2025 Euro Senior Notes | 525.8 | 504.0 | ||||||||||||
| 2027 Dollar Senior Notes | 500.0 | — | ||||||||||||
| Short-term and other borrowings | 114.2 | 109.0 | ||||||||||||
| Unamortized original issue discount | (7.9) | (10.5) | ||||||||||||
| Unamortized deferred financing costs | (33.2) | (31.1) | ||||||||||||
| Total borrowings, net | 4,059.6 | 3,834.1 | ||||||||||||
| Less: | ||||||||||||||
| Short-term borrowings | 24.4 | 19.6 | ||||||||||||
| Current portion of long-term borrowings | 24.3 | 24.3 | ||||||||||||
| Long-term debt | $ | 4,010.9 | $ | 3,790.2 | ||||||||||
|
EXHIBIT NO.
|
DESCRIPTION OF EXHIBITS
|
||||
| 4.2 | |||||
| 31.1 | |||||
| 31.2 | |||||
| 32.1† | |||||
| 32.2† | |||||
| 101 | INS - Inline XBRL Instance Document. The document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document | ||||
| 101 | SCH - Inline XBRL Taxonomy Extension Schema Document | ||||
| 101 | CAL - Inline XBRL Taxonomy Extension Calculation Linkbase Document | ||||
| 101 | DEF - Inline XBRL Taxonomy Extension Definition Linkbase Document | ||||
| 101 | LAB - Inline XBRL Taxonomy Extension Label Linkbase Document | ||||
| 101 | PRE - Inline XBRL Taxonomy Extension Presentation Linkbase Document | ||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | ||||
| † | This certificate is being furnished solely to accompany the report pursuant to 18 U.S.C. Section 1350 and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. | ||||
| AXALTA COATING SYSTEMS LTD. | ||||||||||||||||||||
| Date: | October 26, 2020 | By: /s/ Robert W. Bryant | ||||||||||||||||||
| Robert W. Bryant | ||||||||||||||||||||
| Chief Executive Officer and President | ||||||||||||||||||||
| (Principal Executive Officer) | ||||||||||||||||||||
| Date: | October 26, 2020 | By: /s/ Sean M. Lannon | ||||||||||||||||||
| Sean M. Lannon | ||||||||||||||||||||
| Senior Vice President and Chief Financial Officer | ||||||||||||||||||||
| (Principal Financial Officer) | ||||||||||||||||||||
| Date: | October 26, 2020 | By: /s/ Anthony Massey | ||||||||||||||||||
| Anthony Massey | ||||||||||||||||||||
| Vice President and Global Controller | ||||||||||||||||||||
| (Principal Accounting Officer) | ||||||||||||||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| Snap-on Incorporated | SNA |
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|